References
- Burkitt D. P. Long-term remissions following one-and two-dose chemotherapy for African Lymphomas. Cancer 1967; 20: 756–759
- Magrath I. T., Janus C., Edwards K., et al. An effective therapy for both undifferentiated (including Burk-itt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102–1111
- Sullivan M. P., Ramirez I. Curability of Burk-itt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate and intrathecal chemoprophylaxis. Journal of Clinical Oncology 1985; 3: 627–636
- Patte C., Philip T., Rodary C., et al. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. Journal of Clinical Oncology 1986; 4: 1219–1226
- Ziegler J. L., Bluming A. Z., Fass L., et al. Relapse patterns in Burkitt's lymphoma. Cancer Research 1972; 32: 1267–1272
- Hutchison R. E., Murphy S. B., Fairclough D. L., et al. Diffuse small non-cleaved cell lymphoma in children, Burkitt's versus non-Burkitt's type: Results from the Pediatric Oncology Group and St. Jude Research Hospital. Cancer 1989; 64: 23–28
- Pavlova Z., Parker J. W., Taylor C. R., et al. Small non-cleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and im-munologic features. Cancer 1987; 59: 1892–1902
- Bernstein J. I., Coleman C. N., Strickier J. G., et al. Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt's and non-Burkitt's types). Journal of Clinical Oncology 1986; 4: 847–858
- Strauss D. J., Oppenberg J., Filippa D. A., et al. Small non-cleaved cell lymphoma (undifferentiated lym-phoma-Burkitt's type) is curable in 50% of American adults. Blood 1988; 72: 258a, (abstr)
- Olweny C. L.M., Katongole-Mbidde E., Kaddu-Mukasa A., et al. Treatment of Burkitt's lymphoma: Randomized clinical trial of single agent versus combination chemotherapy. International Journal of Cancer 1976; 17: 436–440
- Cabanillas F. C., Hagemeister F. B., Bodey G. D., et al. IMVP-16: An effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 1982; 60: 693–697
- Cabanillas F. C., Burgess M. A., Bodey G. P., et al. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type. American Journal of Medicine 1983; 74: 382–388
- Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457–481
- Gehan E. A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203–223
- Kalbfleisch J. D., Prentice R. L. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, NY 1980
- Carbone P. P., Kaplan H. S., Mushhoff K., et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research 1971; 31: 1860–1861
- Ziegler J. L., Magrath I. T. Burkitt's lymphoma. Pathobiological Annals 1974; 4: 129–142
- McMaster M. L., Greer J. P., Greco F. A., et al. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. Journal of Clinical Oncology 1991; 9: 941–946
- Philip T., Hartmann O., Biron P., et al. High dose therapy and autologous bone marrow transplantation in partial remission after first line induction therapy for diffuse non-Hodgkin's lymphoma. Journal of Clinical Oncology 1988; 6: 1118–1124